PLANNING WITH INTENSITY-MODULATED RADIOTHERAPY AND TOMOTHERAPY TO MODULATE DOSE ACROSS BREAST TO REFLECT RECURRENCE RISK (IMPORT HIGH TRIAL)

被引:28
作者
Donovan, Ellen M. [1 ]
Ciurlionis, Laura [3 ]
Fairfoul, Jamie [2 ]
James, Hayley [4 ]
Mayles, Helen [5 ]
Manktelow, Sophie [2 ]
Raj, Sanjay [2 ]
Tsang, Yat [3 ]
Tywman, Nicola [2 ]
Yarnold, John [6 ]
Coles, Charlotte [2 ]
机构
[1] Royal Marsden Fdn Trust, Dept Phys, Sutton SM2 5PT, Surrey, England
[2] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Cambridge, England
[3] Mt Vernon Natl Hlth Serv Trust, Watford, Herts, England
[4] Ipswich Hosp Natl Hlth Serv Trust, Ipswich, Suffolk, England
[5] Clatterbridge Natl Hlth Serv Trust, Wirrel, England
[6] Inst Canc Res, Acad Radiotherapy Dept, Sutton, Surrey, England
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 79卷 / 04期
关键词
Breast cancer; Intensity-modulated radiotherapy; Inverse planning; Forward planning; Tomotherapy; RANDOMIZED CLINICAL-TRIAL; CONSERVATIVE TREATMENT; CANCER; IRRADIATION; BOOST;
D O I
10.1016/j.ijrobp.2009.12.052
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To establish planning solutions for a concomitant three-level radiation dose distribution to the breast using linear accelerator- or tomotherapy-based intensity-modulated radiotherapy (IMRT), for the U.K. Intensity Modulated and Partial Organ (IMPORT) High trial. Methods and Materials: Computed tomography data sets for 9 patients undergoing breast conservation surgery with implanted tumor bed gold markers were used to prepare three-level dose distributions encompassing the whole breast (36 Gy), partial breast (40 Gy), and tumor bed boost (48 or 53 Gy) treated concomitantly in 15 fractions within 3 weeks. Forward and inverse planned IMRT and tomotherapy were investigated as solutions. A standard electron field was compared with a photon field arrangement encompassing the tumor bed boost volume. The out-of-field doses were measured for all methods. Results: Dose volume constraints of volume > 90% receiving 32.4 Gy and volume > 95% receiving 50.4 Gy for the whole breast and tumor bed were achieved. The constraint of volume > 90% receiving 36 Gy for the partial breast was fulfilled in the inverse IMRT and tomotherapy plans and in 7 of 9 cases of a forward planned IMRT distribution. An electron boost to the tumor bed was inadequate in 8 of 9 cases. The IMRT methods delivered a greater whole body dose than the standard breast tangents. A contralateral lung volume > 2.5 Gy was increased in the inverse IMRT and tomotherapy plans, although it did not exceed the constraint. Conclusion: We have demonstrated a set of widely applicable solutions that fulfilled the stringent clinical trial requirements for the delivery of a concomitant three-level dose distribution to the breast. (C) 2011 Elsevier Inc.
引用
收藏
页码:1064 / 1072
页数:9
相关论文
共 27 条
  • [1] Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer:: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial
    Bartelink, Harry
    Horiot, Jean-Claude
    Poortmans, Philip M.
    Struikmans, Henk
    Van den Bogaert, Walter
    Fourquet, Alain
    Jager, Jos J.
    Hoogenraad, Willem J.
    Oei, S. Bing
    Warlam-Rodenhuis, Carla C.
    Pierart, Marianne
    Collette, Laurence
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3259 - 3265
  • [2] Bentzen SM, 2008, LANCET, V371, P1098, DOI 10.1016/S0140-6736(08)60348-7
  • [3] Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer
    Blom-Goldman, Ulla
    Svane, Gunilla
    Wennberg, Berit
    Lidestahl, Anders
    Lind, Pehr A. R. M.
    [J]. ACTA ONCOLOGICA, 2007, 46 (02) : 187 - 193
  • [4] The IMPORT trials are launched (September 2006)
    Coles, C.
    Yarnold, J.
    [J]. CLINICAL ONCOLOGY, 2006, 18 (08) : 587 - 590
  • [5] The IMPORT gold seed study: Evaluation of tumour bed localisation and image-guided radiotherapy for breast cancer
    Coles, C. E.
    Wishart, G.
    Donovan, E.
    Harris, E.
    Poynter, A.
    Twyman, N.
    Routsis, D.
    Wilkinson, J.
    Yarnold, J.
    [J]. CLINICAL ONCOLOGY, 2007, 19 (03) : S26 - S27
  • [6] Clinical use of a commercial Monte Carlo treatment planning system for electron beams
    Cygler, JE
    Lochrin, C
    Daskalov, GM
    Howard, M
    Zohr, R
    Esche, B
    Eapen, L
    Grimard, L
    Caudrelier, JM
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2005, 50 (05) : 1029 - 1034
  • [7] REANALYSIS AND RESULTS AFTER 12 YEARS OF FOLLOW-UP IN A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY WITH LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER
    FISHER, B
    ANDERSON, S
    REDMOND, CK
    WOLMARK, N
    WICKERHAM, DL
    CRONIN, WM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) : 1456 - 1461
  • [8] Formenti S, 2004, INT J RADIAT ONCOL, V60, pS397, DOI 10.1016/S0360-3016(04)01573-1
  • [9] Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer
    Gagliardi, G
    Lax, I
    Söderström, S
    Gyenes, G
    Rutqvist, LE
    [J]. RADIOTHERAPY AND ONCOLOGY, 1998, 46 (01) : 63 - 71
  • [10] Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
    Graham, MV
    Purdy, JA
    Emami, B
    Harms, W
    Bosch, W
    Lockett, MA
    Perez, CA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02): : 323 - 329